zolmitriptan

FDA Drug Profile — ZOMIG, zolmitriptan, zolmiptriptan

zolmitriptan is listed in the FDA National Drug Code directory with 9 NDC codes, marketed under brand names including ZOMIG, zolmitriptan, zolmiptriptan. Available dosage forms: powder, tablet, film coated, spray, tablet, orally disintegrating.

Drug details

Generic Name
zolmitriptan
Brand Names
ZOMIG, zolmitriptan, zolmiptriptan
Application Number
ANDA207867
Sponsor
Jubilant Biosys Limited
NDC Codes
9
Dosage Forms
POWDER, TABLET, FILM COATED, SPRAY, TABLET, ORALLY DISINTEGRATING
Routes
ORAL, NASAL
Active Ingredients
ZOLMITRIPTAN

Indications and Usage

1 INDICATIONS AND USAGE Zolmitriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Only use zolmitriptan tablets if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan tablets treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan tablets are administered to treat any subsequent attacks. Zolmitriptan tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of zolmitriptan tablets have not been established for cluster headache. Zolmitriptan tablets are a serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults ( 1 ) Limitations of Use : Use only after a clear diagnosis of migraine has been established ( 1 ) Not indicated for the prophylactic therapy of migraine ( 1 ) Not indicated for the treatment of cluster headache ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.